Clinical Trial Update: Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study

View source ↗

Summary

A clinical trial evaluating interventions for CADASIL is currently recruiting, sponsored by the University of Wisconsin, Madison.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cadasil

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: CADASIL | Status: RECRUITING